Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 17


Chemoprevention in patients with genetic risk of colorectal cancers.

Laukaitis CM, Erdman SH, Gerner EW.

Colorectal Cancer. 2012;1(3):225-240.


The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.

Cohen SA, Leininger A.

Appl Clin Genet. 2014 Jul 22;7:147-58. doi: 10.2147/TACG.S51483. eCollection 2014. Review.


A case of synchronous double primary breast carcinoma and osteosarcoma: Mismatch repair genes mutations as a possible cause for multiple early onset malignant tumors.

Ahmed H, Salama A, Salem SE, Bahnassy AA.

Am J Case Rep. 2012;13:218-23. doi: 10.12659/AJCR.883382. Epub 2012 Sep 10.


Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.

von Bueren AO, Bacolod MD, Hagel C, Heinimann K, Fedier A, Kordes U, Pietsch T, Koster J, Grotzer MA, Friedman HS, Marra G, Kool M, Rutkowski S.

Br J Cancer. 2012 Oct 9;107(8):1399-408. doi: 10.1038/bjc.2012.403. Epub 2012 Sep 13.


The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative.

Martín-López JV, Barrios Y, Medina-Arana V, Andújar M, Lee S, Gu L, Li GM, Rüschoff J, Salido E, Fishel R.

Carcinogenesis. 2012 Sep;33(9):1647-54. doi: 10.1093/carcin/bgs199. Epub 2012 Jun 27.


Anticipation in lynch syndrome: where we are where we go.

Bozzao C, Lastella P, Stella A.

Curr Genomics. 2011 Nov;12(7):451-65. doi: 10.2174/138920211797904070.


Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice.

Kovtun IV, Harris KJ, Jatoi A, Jevremovic D.

Carcinogenesis. 2011 Jul;32(7):1085-92. doi: 10.1093/carcin/bgr080. Epub 2011 May 5.


Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.

Kyritsis AP, Bondy ML, Levin VA.

Nutr Cancer. 2011;63(2):174-84. doi: 10.1080/01635581.2011.523807. Review.


Inherited predisposition to glioma.

Kyritsis AP, Bondy ML, Rao JS, Sioka C.

Neuro Oncol. 2010 Jan;12(1):104-13. doi: 10.1093/neuonc/nop011. Epub 2009 Nov 23. Review.


A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory.

van Lier MG, Wagner A, van Leerdam ME, Biermann K, Kuipers EJ, Steyerberg EW, Dubbink HJ, Dinjens WN.

J Cell Mol Med. 2010 Jan;14(1-2):181-97. doi: 10.1111/j.1582-4934.2009.00977.x. Epub 2009 Nov 19. Review.


Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.

Heinen CD.

Mutat Res. 2010 Nov 10;693(1-2):32-45. doi: 10.1016/j.mrfmmm.2009.09.004. Epub 2009 Sep 17. Review.


Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.

Stulp RP, Herkert JC, Karrenbeld A, Mol B, Vos YJ, Sijmons RH.

Hered Cancer Clin Pract. 2008 Feb 15;6(1):15-21. doi: 10.1186/1897-4287-6-1-15.


Analysis of microsatellite instability in medulloblastoma.

Viana-Pereira M, Almeida I, Sousa S, Mahler-Araújo B, Seruca R, Pimentel J, Reis RM.

Neuro Oncol. 2009 Oct;11(5):458-67. doi: 10.1215/15228517-2008-115. Epub 2009 Jan 29.


Type A microsatellite instability in pediatric gliomas as an indicator of Turcot syndrome.

Giunti L, Cetica V, Ricci U, Giglio S, Sardi I, Paglierani M, Andreucci E, Sanzo M, Forni M, Buccoliero AM, Genitori L, Genuardi M.

Eur J Hum Genet. 2009 Jul;17(7):919-27. doi: 10.1038/ejhg.2008.271. Epub 2009 Jan 21.


Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance.

Hofstra RM, Spurdle AB, Eccles D, Foulkes WD, de Wind N, Hoogerbrugge N, Hogervorst FB; IARC Unclassified Genetic Variants Working Group.

Hum Mutat. 2008 Nov;29(11):1292-303. doi: 10.1002/humu.20894.


Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding.

Cyr JL, Heinen CD.

J Biol Chem. 2008 Nov 14;283(46):31641-8. doi: 10.1074/jbc.M806018200. Epub 2008 Sep 11.


The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A.

Gastroenterology. 2008 Aug;135(2):419-28. doi: 10.1053/j.gastro.2008.04.026. Epub 2008 May 2.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk